JESSICA NEAL: Open Payments
NPI 1710314034 · GIG HARBOR, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 80 payments from 12 companies in 2025. Trend: 2023 $310 · 2024 $797 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $472 |
| Janssen Biotech, Inc. | 11 | $179 |
| Organon LLC | 12 | $124 |
| Incyte Corporation | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| UCB, Inc. | 3 | $53 |
| Arcutis Biotherapeutics, Inc. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
| GENZYME CORPORATION | 1 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: SKYRIZI, RINVOQ, TREMFYA, DUPIXENT, HADLIMA, OPZELURA, Bimzelx, Zoryve.
Industry payments across WA — which companies pay providers there.
